Editor’s Choice: GEA vs MAC in high-risk patients undergoing ERCP

GIE Associate Editor, Dr. Sharmila Anandasabapath, highlights this article from the April issue “A randomized controlled trial evaluating general endotracheal anesthesia versus monitored anesthesia care and the incidence of sedation-related adverse events during ERCP in high-risk patients” by Zachary L. Smith, DO, et al.  This is one of the few studies which compare, via a randomized …

Continue reading Editor’s Choice: GEA vs MAC in high-risk patients undergoing ERCP

Editor’s Choice: Role of interventional inflammatory bowel disease in the era of biologic therapy

GIE Senior Associate Editor, Dr. John R. Saltzman, MD, highlights this article from the February issue “Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group” by Bo Shen, MD, et al.  There is an increasing recognition that Interventional (or therapeutic) inflammatory bowel disease …

Continue reading Editor’s Choice: Role of interventional inflammatory bowel disease in the era of biologic therapy

Editor’s Choice: Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program

GIE Associate Editor, Dr. Lyndon V. Hernandez, MD MPH, highlights this article from the January issue “Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program” by Maxime E.S. Bronzwaer, MD, et al.  In 2006, Barclay et al showed in their landmark study in The New England Journal of Medicine the association between …

Continue reading Editor’s Choice: Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program

Editor’s Choice: The emerging role of histologic disease activity assessment in ulcerative colitis

GIE Editor-in-Chief, Dr. Michael Wallace, highlights this article from the December issue “The emerging role of histologic disease activity assessment in ulcerative colitis” by Rish K. Pai, MD, PhD, et al.  The decision about when to start and stop therapy for ulcerative colitis is increasingly made based on colonoscopy and histological assessment of activity ("treat …

Continue reading Editor’s Choice: The emerging role of histologic disease activity assessment in ulcerative colitis

Editor’s Choice: Screening for esophageal squamous cell carcinoma

Associate Editor, Dr. Fauze Maluf-Filho, highlights this article from the September issue “Screening for esophageal squamous cell carcinoma: recent advances” by Don C. Codipilly, MD, et al.  This study provides a thorough review of the current technologies (endoscopic and non-endoscopic) to screen for esophageal squamous cell carcinoma (ESCC). It also points out future directions for …

Continue reading Editor’s Choice: Screening for esophageal squamous cell carcinoma

Editor’s Choice: Risk factors for gastric adenocarcinoma

Associate Editor, Dr. Sharmila Anandasabapathy, highlights this article from the April issue “Association of gastric intestinal metaplasia and East Asian ethnicity with the risk of gastric adenocarcinoma in a U.S. population” by Alyssa Y. Choi, MD, et al.  In the United States, gastric adenocarcinoma is the forgotten stepchild, often believed to be a disease of …

Continue reading Editor’s Choice: Risk factors for gastric adenocarcinoma

Editor’s Choice: Inadequate Boston Bowel Preparation Scale scores predict the risk of missed neoplasia

Associate Editor, Dr. Seth Gross, highlights this article from the March issue “Inadequate Boston Bowel Preparation Scale scores predict the risk of missed neoplasia on the next colonoscopy” by Matthew A. Kluge, MD, et al.  This article further supports the notion of the importance of bowel preparation and its impact on adenoma detection. The study demonstrates …

Continue reading Editor’s Choice: Inadequate Boston Bowel Preparation Scale scores predict the risk of missed neoplasia